Post-Approval Study of the Tecnis® Toric IOL
- Conditions
- Cataract
- Registration Number
- NCT02566083
- Lead Sponsor
- Abbott Medical Optics
- Brief Summary
This study is a prospective, multicenter, bilateral, non-randomized, open-label, comparative clinical study conducted at up to 80 sites in the USA. Subjects will choose to be bilaterally implanted with either 1) the TECNIS 1-Piece Toric IOLs, Model ZCT300 and/or ZCT400, or 2) the TECNIS Monofocal Model ZCB00 non-toric control IOL, according to subject preference
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 365
-
Minimum 22 years of age
-
Bilateral cataracts
-
Preoperative keratometric cylinder in both eyes
-
Most appropriate toric IOL model choice (ZCT300 or ZCT400)
-
Predicted residual refractive cylinder, based on the AMO Toric IOL Calculator, must be:
≤ 0.69 D for a ZCT300 IOL or ≤ 0.88 D for a ZCT400 IOL
-
Clear intraocular media other than cataract in each eye
-
Availability, willingness, ability and sufficient cognitive awareness to comply with examination procedures and study visits
-
Ability to understand, read and write English in order to consent to study participation and complete a study questionnaire
-
Signed informed consent and HIPAA authorization
- Irregular corneal astigmatism
- Any corneal pathology/abnormality other than regular corneal astigmatism
- Previous corneal surgery
- Recent ocular trauma or intraocular surgery that is not resolved/stable or may affect visual outcomes
- Any pupil abnormalities
- Subjects with conditions associated with increased risk of zonular rupture, including capsular or zonular abnormalities that may lead to IOL decentration, including pseudoexfoliation, trauma, or posterior capsule defects
- Known ocular disease or pathology that may affect visual acuity or that may require surgical intervention during the course of the study
- Concurrent participation or participation during 30 days prior to preoperative visit in any other clinical study
- Planned monovision correction
- Patient is pregnant, plans to become pregnant, is lactating or has another condition associated with the fluctuation of hormones that could lead to refractive changes
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Rate of Severe Visual Distortions 6 months The rate of severe visual distortions under overall circumstances for the five visual distortion items of interest (lines that slant, tilt, split or separate; flat surfaces appearing curved; objects appearing further away or closer than they are; objects appearing to have a different size or shape; and physical discomfort related to vision). The six month data were used for this endpoint if available and if not an earlier visit was used. If a subject had a lens repositioning the questionnaire prior to the repositioning was used if available.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (44)
Eye Center South
🇺🇸Dothan, Alabama, United States
Arizona Eye Cente
🇺🇸Chandler, Arizona, United States
Fishkind, Bakewell & Maltzman Eye Care & Surgery Cente
🇺🇸Tucson, Arizona, United States
Boozman-Hof Regional Eye Clinic
🇺🇸Rogers, Arkansas, United States
Empire Eye & Laser Center
🇺🇸Bakersfield, California, United States
Atlantis Eye Care
🇺🇸Huntington Beach, California, United States
Scripps Clinic Medical Group
🇺🇸La Jolla, California, United States
Southern California Eye Physicians & Associates
🇺🇸Long Beach, California, United States
Feinerman Vision Center
🇺🇸Newport Beach, California, United States
Coastal Vision
🇺🇸Orange, California, United States
Scroll for more (34 remaining)Eye Center South🇺🇸Dothan, Alabama, United States